237
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Haemophilia in extreme immature preterm infants: increased risk for intracranial haemorrhage?

, , , &
Pages 621-624 | Received 28 Apr 2013, Accepted 12 Jul 2013, Published online: 20 Aug 2013

References

  • Kenet G, Chan AK, Soucie JM, Kulkarni R. Bleeding disorders in neonates. Haemophilia 2010;16:168–75
  • Ljung RC. Intracranial haemorrhage in haemophilia A and B. Br J Haematol 2008;140:378–84
  • Towner D, Castro MA, Eby-Wilkens E, Gilbert WM. Effect of mode of delivery in nulliparous women on neonatal intracranial injury. N Engl J Med 1999;341:1709–14
  • Riskin A, Riskin-Mashiah S, Bader D, et al. Delivery mode and severe intraventricular hemorrhage in single, very low birth weight, vertex infants. Obstet Gynecol 2008;112:21–8
  • Kurnik K, Bidlingmaier C, Engl W, et al. New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor development. Haemophilia 2010;16:256–62
  • McCrea HJ, Ment LR. The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate. Clin Perinatol 2008;35:777–92, vii
  • Kuperman AA, Kenet G, Papadakis E, Brenner B. Intraventricular hemorrhage in preterm infants: coagulation perspectives. Semin Thromb Hemost 2011;37:730–6
  • Bidlingmaier C, Bergmann F, Kurnik K. Haemophilia A in two premature infants. Eur J Pediatr 2005;164:70–2
  • Cartledge P, Deakin K, McKecknie L, Richards M. A case report of a premature infant with haemophilia A and factor VIII inhibitor. Haemophilia 2011;17:711–2
  • Gale RF, Hird MF, Colvin BT. Management of a premature infant with moderate haemophilia A using recombinant factor VIII. Haemophilia 1998;4:850–3
  • Gelbart B, Barnes C. Severe haemophilia and extreme prematurity–a case report. Haemophilia 2009;15:352–4
  • Kraft KE, Verlaak R, van Heijst AF, et al. Management of haemophilia in three premature infants. Haemophilia 2008;14:378–80
  • Gray OP, Ackerman A, Fraser AJ. Intracranial haemorrhage and clotting defects in low-birth-weight infants. Lancet 1968;1:545–8
  • Petaja J, Hiltunen L, Fellman V. Increased risk of intraventricular hemorrhage in preterm infants with thrombophilia. Pediatr Res 2001;49:643–6
  • Gould SJ, Howard S, Hope PL, Reynolds EO. Periventricular intraparenchymal cerebral haemorrhage in preterm infants: the role of venous infarction. J Pathol 1987;151:197–202
  • Chalmers EA, Williams MD, Richards M, et al. Management of neonates with inherited bleeding disorders–a survey of current UK practice. Haemophilia 2005;11:186–7
  • Kulkarni R, Ponder KP, James AH, et al. Unresolved issues in diagnosis and management of inherited bleeding disorders in the perinatal period: a White Paper of the Perinatal Task Force of the Medical and Scientific Advisory Council of the National Hemophilia Foundation, USA. Haemophilia 2006;12:205–11
  • MacLean PE, Fijnvandraat K, Beijlevelt M, Peters M. The impact of unaware carriership on the clinical presentation of haemophilia. Haemophilia 2004;10:560–4
  • Klinge J, Auberger K, Auerswald G, et al. Prevalence and outcome of intracranial haemorrhage in haemophiliacs–a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH). Eur J Pediatr 1999;158:S162–5
  • Ljung R. The optimal mode of delivery for the haemophilia carrier expecting an affected infant is vaginal delivery. Haemophilia 2010;16:415–9
  • James AH, Hoots K. The optimal mode of delivery for the haemophilia carrier expecting an affected infant is caesarean delivery. Haemophilia 2010;16:420–4
  • Madan B, Street AM. What is the optimal mode of delivery for the haemophilia carrier expecting an affected infant-vaginal delivery or caesarean delivery? Haemophilia 2010;16:425–6
  • Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988;72:1651–7
  • Reverdiau-Moalic P, Delahousse B, Body G, et al. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996;88:900–6
  • Gouw SC, van der Bom JG, Marijke van den Berg H. Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study. Blood 2007;109:4648–54

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.